Skip to main content
Caplight Logo









Onselex Pharmaceuticals

Onselex Pharmaceuticals

Private
New York City, New YorkHealthcare & Life Scienceshttps://onselex.com/

Last Round

VC Round

Aug 25, 2020

Total Funding Raised

$1.3M

Company Overview

Onselex Pharmaceuticals operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a VC Round in August 2020.

Onselex Pharmaceuticals is a biotechnology company that develops nanoparticle-based oncology medications designed to improve the therapeutic index of established cancer drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Onselex Pharmaceuticals Comparables

Compare Onselex Pharmaceuticals with similar companies based on industry and business-model similarity.

Onselex Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cession Oncology
85%
NanOlogy, LLC
83%
Nanobots Therapeutics
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Onselex Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 25, 2020
SeedMar 19, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ernie Shin

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 25, 2020

    $2.17M round raised.

Book a demo to see all signals

For institutional investors. Book with your work email.

Onselex Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Onselex Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Onselex Pharmaceuticals's valuation, stock price, and market status.

Is Onselex Pharmaceuticals a public or private company?

Onselex Pharmaceuticals is a private company.

What is the current stock price of Onselex Pharmaceuticals?

Onselex Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Onselex Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Onselex Pharmaceuticals worth (valuation)?

Valuation information for Onselex Pharmaceuticals is not publicly available.

Can I buy Onselex Pharmaceuticals stock?

Onselex Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Onselex Pharmaceuticals's last funding round?

Onselex Pharmaceuticals's most recent funding round was VC Round on August 25, 2020.

Who are the main investors in Onselex Pharmaceuticals?

Investor information for Onselex Pharmaceuticals is not publicly disclosed.

Will Onselex Pharmaceuticals IPO soon?

No public IPO plans have been announced for Onselex Pharmaceuticals.

How can I track Onselex Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades in Onselex Pharmaceuticals's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range4
Year Founded2018
Last FundingAug 25, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?